
Experimental evolution offers a powerful framework to investigate bacterial adaptation dynamics. In this study, we performed long-term evolution experiments over an estimated 376 generations under glucose-limited conditions using 2 clinical avian pathogenic Escherichia coli (APEC) lineages with strain 729-021014-1-4 representing sequence type 95 (ST95-729-021014-1-4) and strain 729-141114-1-15 representing ST131 (ST131-729-141114-1-15). Whole-genome sequencing of isolates across eight time points revealed distinct adaptive trajectories. The ST95-729-021014-1-4 lineage exhibited a rapid adaptation strategy characterized by a relatively high mutation accumulation rate. Sequence-based analysis predicted the transcriptional upregulation of the anti-adaptor protein IraP via a promoter mutation and the translational optimization of metabolic genes via synonymous codon changes as primary drivers of its improved growth rate. Conversely, the ST131-729-141114-1-15 lineage displayed a conservative evolutionary pattern with a lower mutation rate and minor growth rate improvement, suggesting a pre-adapted state that relied on genomic maintenance rather than extensive regulatory remodelling. Its mutations were largely restricted to envelope-associated genes and synonymous variants with reduced translational efficiency. While both lineages maintained clonal stability, their differential mutation strategies highlight lineage-specific potentials for adaptation. These findings provide critical insights into how different APEC clinical isolates may persist and evolve during the typical production cycle of poultry, underscoring the diversity of evolutionary strategies.
Group B Streptococcus (GBS) is a major agent of perinatal infections. Although extensively studied as a pathogen in pregnant individuals and neonates, little is known about GBS from male adults, despite occasional reports of its occurrence in semen. We characterized 120 GBS isolates obtained from semen samples in Brazil between 2017 and 2022 to determine serotypes, antimicrobial susceptibility profile, virulence-associated determinants, clustered regularly interspaced short palindromic repeats (CRISPR) diversity and phylogenetic relationships with isolates from other clinical sources. Serotype V was the most frequent, followed by Ia, Ib, III, II and IV. Resistance was observed for tetracycline (84.1%), erythromycin (30.8%), levofloxacin (8.3%) and 12.5% exhibited multidrug resistance (MDR). The most common sequence types (STs) were ST1, ST144 and ST19. The isolates clustered into five major clonal complexes (CC1, CC17, CC19, CC23 and CC24) and six singletons. Serotypes, antimicrobial resistance and virulence-associated determinants markers varied across CCs. Resistance determinants detected included tetM, mefA, msrD, ermA and ermB . Levofloxacin-resistant isolates contained mutations in gyrA and/or parC and were predominantly linked to the serotype V/ST19 lineage. All isolates except one carried at least one alpha-like protein (Alp) gene. Phylogenetic analysis of isolates from semen, rectovaginal samples, urine and invasive infections showed that isolates clustered according to CC regardless of clinical source. CRISPR1 analysis revealed intra-clonal diversity, as isolates within the same CC displayed different CRISPR compositions. These findings indicate that GBS isolates recovered from semen belong to established GBS lineages also identified in other clinical sources and support the co-circulation of GBS lineages across different human niches.
The Nostocales are filamentous cyanobacteria that include bloom-forming, nitrogen-fixing species with major ecological and biotechnological relevance. Owing to their metabolic diversity, nitrogen-fixing capabilities and nutritional profile, they hold potential for various biotechnological applications including the production of nutraceuticals and biofertilizers. However, the capacity of certain Nostocales species to produce cyanotoxins also raises health concerns. This study provides a comparative bioinformatic analysis of 161 Nostocales genomes from the National Center for Biotechnology Information (NCBI) and three newly sequenced Aphanizomenon flos-aquae (AFA) strains, including Klamath AFA, with a focus on taxonomy, cyanotoxin-associated biosynthetic gene clusters (BGCs), natural competence, restriction-modification systems and vitamin B-12 metabolism. Our analysis supports reassessment of several AFA-labelled genomes and refines the boundaries of the core AFA cluster. Cyanotoxinassociated BGCs, specifically for anatoxin-a, saxitoxin, cylindrospermopsin and microcystin/nodularin, were detected in only 7.3% of the genomes. Natural competence genes required for horizontal gene transfer were found in 89.6% of the genomes, although the presence of multiple restriction-modification system-associated proteins in Nostocales species, especially Aphanizomenon, Anabaena, Dolichospermum and Nostoc sp. may limit foreign gene acquisition. Additionally, similar to 30% of the genomes harbour a shared btu operon arrangement associated with B-12 import, observed here across multiple Nostocales genera. B-12 content in the AFA strains was measured at similar to 0.4-0.5 & micro;g g(-1 )dry biomass and is likely linked to associated B-12-producing bacteria. Fluorescent B-12 analogue uptake experiments in NIES 4052 and Klamath AFA support a model for the uptake of exogenous B-12 in these strains. Together with the detection of cobalamin-producing commensal bacteria, this suggests that B(12 )in AFA biomass may be linked to cyanobacterium-bacteria interactions. Overall, this study provides a genomic and experimental framework for evaluating the taxonomy, safety, genetic tractability and nutritional potential of AFA and related Nostocales.
Aeromonas taxonomy has long been complicated by overlapping phenotypic, biochemical and protein profiles. Here, we establish a robust genome-based framework for Aeromonas genomic species delineation. We analysed average nt identity (ANI) across 4,366 available Aeromonas genomes and demonstrated that at a 96% ANI threshold, skANI and fastANI generated too many clusters (65 and 57, respectively) and these clusters were not supported by coregenome phylogeny. We identified 95.4% skANI (equivalent to 95.6% fastANI) as an operational threshold for delineating Aeromonas genomic species. Using the 95.4% skANI threshold, we identified 44 ANI clusters among the 4,366 genomes, of which 43 clusters were genomic species supported by the coregenome phylogeny. Thirty-four of the 43 genomic species corresponded to existing taxonomic species, whilst the remaining 9 are currently not recognised as taxonomic species. All recognised taxonomic species represented in the dataset retained their existing species designation except Aeromonas mytilicola, which was not separated from Aeromonas rivipollensis in both ANI clusters and the coregenome phylogeny. The digital DNA-DNA hybridisation values between the genomic species were below 70%, further supporting genomic species delineation. We further developed AeromonasGStyper, a genomic species typing tool that assigns query genomes based on ANI similarity to medoid genomes. In conclusion, this study establishes a genomic species framework for genome-based classification of Aeromonas and provides a practical approach for future genomic surveillance. Impact Statement Aeromonas species have gained increased attention as emerging human enteric pathogens. Aeromonas taxonomy has long been complicated by overlapping phenotypic, biochemical and protein profiles. Although a 96% average nt identity (ANI) threshold was proposed previously for Aeromonas species delineation, analysis of 4,366 Aeromonas genomes demonstrated that this threshold generated excessive genomic clusters that were not supported by the coregenome phylogeny. We identified 95.4% skANI (equivalent to 95.6% fastANI) as an operational threshold for delineating Aeromonas genomic species, supported by coregenome phylogeny and digital DNA-DNA hybridisation. The framework identified 43 genomic species, including 34 corresponding to recognised taxonomic species and 9 genomic species that do not correspond to currently recognised taxonomic species. In addition, our data showed that Aeromonas mytilicola was not separated from Aeromonas rivipollensis by ANI clustering and coregenome phylogeny, supporting further taxonomic reassessment of the distinction between these two species.
Differences in host distribution are observed across Mycobacterium tuberculosis complex (MTBC) lineages, but investigating the molecular basis of host compatibility in vivo is challenging. Here, we establish an epidemiology-guided in vitro framework to operationalize 'host compatibility' as a theoretical parameter that can be approximated experimentally using macrophage infection readouts. We infected two widely used but biologically distinct models, human THP-1-derived macrophages (THP-1m) and bovine macrophages (BoMac), with four MTBC human and animal strains. We quantified infected-cell frequency, intracellular bacterial burden dynamics, cell death and host transcriptome by RNA-seq. Across both models, infection phenotypes were concordant with the a priori epidemiology-informed reference pairings: the most compatible strain showed a higher late intracellular bacterial burden in its respective host, and the corresponding transcriptomes were enriched for replication, repair and cell-cycle signatures, whereas the opposite pairings showed lower bacterial burdens and stronger enrichment for endosomal, antigen-presentation and immune-signalling pathways in each cell type. Given the role of phospholipase C and virulence, we assessed plc expression and performed pharmacological inhibition experiments. These analyses revealed lineage-and macrophage-context-dependent expression patterns and reduced intracellular burden and cytotoxicity in THP-1m but not in BoMac. This framework links MTBC strain diversity to macrophage infection phenotypes and prioritizes candidate pathways potentially involved in bacterial-host interactions.